Biology and clinical application of the NIS gene

Tumori

Volumn 89, Issue 5, 2003, Pages 523-528

  Elisei, Rossella ^a   Vivaldi, Agnese ^a   Pacini, Furio ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Active iodide transport; NIS expression; NIS therapy; Sodium iodide; Symporter (NIS); Thyroid cancer

Indexed keywords

COMPLEMENTARY DNA; DEPSIPEPTIDE; FR 901228; HISTONE DEACETYLASE INHIBITOR; IODIDE; MEMBRANE PROTEIN; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER;

BASOLATERAL MEMBRANE; BREAST CARCINOMA; CANCER CELL; CONGENITAL HYPOTHYROIDISM; HASHIMOTO DISEASE; HUMAN; MOLECULAR CLONING; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; THYROID CANCER; THYROID CARCINOMA; THYROID DISEASE; THYROID FOLLICLE CELL; TUMOR CELL;

EID: 0346996607     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900513     Document Type: Review

References (20)

1. Carrasco N: Iodide transport in the thyroid gland. Biochem Biophys Acta; 1154: 65-82,1993.
2. Smanik PA, Liu Q, Furminger TL, Ryu KY, Xing S, Mazzaferri EL, Jihang SM: Cloning of the human sodium symporter. Biochem Biophys Res Comm, 226: 339-345,1996.
3. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N: The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med, 6: 871-878, 2000.
4. Spitzweg C, Morris J: The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin Endocrinol, 57: 559-574, 2002.
5. Taki K, Kogai T, Kanamoto Y, Hershman JM, Brent GA: A thyroid specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells. Mol Endocrinol, 16: 2266-2282, 2002.
6. Wu SY, Kollin J, Coodley E, Lockyer T, Lyons KP, Moran E, Parker LN, Yu AC: I-131 total-body scan: localization of disseminated gastric adenocarcinoma. Case report and survey of the literature. J Nucl Med, 25: 1204-1209, 1984.
7. Greyson ND: Salivary glands. In: Clinical nuclear medicine, Maisey MN, Britton KE, Collier BD (Eds), pp 557-565, 3rd ed, Chapman & Hall Medical Press, London, 1998.
8. Muhammad M, Hammai M, Bakeet S: Radiodine breast uptake in non breast feeding women: clinical and scintigraphic characteristics. J Nucl Med, 39: 1452-1454, 1995.
9. Upadhyay G, Singh R, Agarwal G, Mishra SK, Pal L, Pradhan PK, Das BK, Godbole MM: Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue. Breast Cancer Res Treat, 77: 157-165, 2003.
10. Pohlenz J, Refetoff S: Mutations in the sodium/iodide symporter (NIS) gene as a cause of the iodide transport defects and congenital hypothyroidism. Biochimie, 81: 469-476, 1999.
11. Russo D, Manole D, Arturi F, Suarez HG, Schlumberger M, Filetti S, Derwahl M: Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas. Thyroid, 11: 37-39, 2001.
12. Tonacchera M, Agretti P, Ceccarini G, Lenza R, Refetoff S, Santini F, Pinchera A, Chiovato L, Vitti P: Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur J Endocrinol, 144: 611-618, 2001.
13. Simon D, Koehrle J, Reiners C, Boemer AR, Schmutzler C, Mainz K, Goretzki PE, Roeher HD: Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary carcinoma. World J Surgery, 22: 569-574, 1998.
14. Schmutzler C, Winer R, Meissner-Weigl J, Koehrle J: Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in non transformed FRTL-5 rat thyroid cell line. Biochem Biophys Res Comm, 240: 832-838, 1997.
15. Kitazono M, Robey R, Zhan Z, Sarlis NJ, Skarulis MC, Aikou T, Bates S, Fojo T: Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab, 86: 3430-3435, 2001.
16. Kogai T, Hershaman JM, Motomura K, Endo T, Onaya T, Brent GA: Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and in normal thyroid cells. Endocrinology, 142: 3369-3379, 2001.
17. Ciampi R, Vivaldi A, Romei C, Galleri L, Cosci B, Giannini R, Faviana P, Basolo F, Santini F, Elisei R: Iodide uptake is induced by sodium iodide symporter (NIS) gene transfection but not by retinoic acid treatment in anaplastic (FRO) and medullary (TT) human thyroid cancer cell lines. J Clin Invest, 25 (Suppl 5): 8, 2002.
18. Huang M, Batra RK, Kogai T, Lin YQ, Hershman JM, Lichtenstein A, Sharma S, Zhu LX, Brent GA, Dubinett SA: Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Therapy, 8: 612-618, 2001.
19. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N: The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Rev, 24: 48-77, 2003.
20. Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA: Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA, 97: 8519-8524, 2000.